Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lilly Humulin package label must designate Novo Nordisk's NovoPen trademarks, court rules.

Executive Summary

LILLY HUMULIN (HUMAN INSULIN) PACKAGE LABEL WILL BE MODIFIED to indicate that the NovoPen and NovolinPen trademarks referred to on the label are registered trademarks of Novo Nordisk, under a court order handed down by the U.S. District Court for the Southern District of New York. Lilly is "enjoined from distributing to wholesalers Humulin insulin cartridges in their current packaging which does not attribute ownership of" Novo Nordisk's trademarks, the Aug. 30 order states. The injunction does not effect products already shipped to wholesalers or retailers.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS028901

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel